Bicycle Therapeutics Plc (BCYC)
4.865
-0.28
(-5.53%)
USD |
NASDAQ |
May 07, 13:24
Bicycle Therapeutics Cash from Investing (Quarterly) : -0.7118M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 0.00 |
| NuCana Plc | -0.0656M |
| DBV Technologies SA | -0.7165M |
| Cellectis SA | 22.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -65.81M |
| Cash from Financing (Quarterly) | -0.0539M |
| Free Cash Flow | -231.83M |
| Free Cash Flow Per Share (Quarterly) | -0.9547 |
| Free Cash Flow to Equity (Quarterly) | -64.95M |
| Free Cash Flow to Firm (Quarterly) | -66.48M |
| Free Cash Flow Yield | -68.66% |